Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenfang Du

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Molecular Cancer|February 20, 2018
Mechanisms of receptor tyrosine kinase activation in cancerZhenfang Du, Christine M Lovly
Antonie Van Leeuwenhoek|July 18, 2025
The DR2416/DR2415 two-component system is responsible for the radioresistance of Deinococcus radioduransWuzhou Wang, Zhenfang Du, Fei Yang, et al.
International Journal of Biological Sciences|January 12, 2026
RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signalingZhenfang Du, Lili Li, Xingsheng Shu, et al.
Biochemistry|March 27, 2026
Microproteins in Human Physiology and PathologyZhenfang Du, Felix-Antoine Trifiro, Marie A Brunet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2018
MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2Hui Zhang, Qing Ye, Zhenfang Du, et al.
Oncotarget|March 5, 2016
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylationZhenfang Du, Lili Li, Xin Huang, et al.
Journal of Ethnopharmacology|September 16, 2023
Guben Xiezhuo Decoction inhibits M1 polarization through the Raf1/p-Elk1 signaling axis to attenuate renal interstitial fibrosisYue Liu, Jingyi Wu, Shuo Liang, et al.
Phytotherapy Research : PTR|September 17, 2025
Crocin Attenuates Nrf2/GPX4 Mediated Ferroptosis in Obstructive Nephropathy by Selectively Targeting MKK4Ziyun Xu, Liwei Zhu, Jingyi Wu, et al.
Biomolecules|February 25, 2023
Structure-Guided Strategies of Targeted Therapies for Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung CancerZhenfang Du, Jinghan Sun, Yunkai Zhang, et al.
Cell Death Discovery|August 19, 2025
Diverse functions of NLRP3 inflammasome in PANoptosis and diseasesYuanyuan Jiang, Zhiyuan Qiang, Yue Liu, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Molecular Cancer|February 20, 2018
Mechanisms of receptor tyrosine kinase activation in cancerZhenfang Du, Christine M Lovly
Antonie Van Leeuwenhoek|July 18, 2025
The DR2416/DR2415 two-component system is responsible for the radioresistance of Deinococcus radioduransWuzhou Wang, Zhenfang Du, Fei Yang, et al.
International Journal of Biological Sciences|January 12, 2026
RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signalingZhenfang Du, Lili Li, Xingsheng Shu, et al.
Biochemistry|March 27, 2026
Microproteins in Human Physiology and PathologyZhenfang Du, Felix-Antoine Trifiro, Marie A Brunet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2018
MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2Hui Zhang, Qing Ye, Zhenfang Du, et al.
Oncotarget|March 5, 2016
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylationZhenfang Du, Lili Li, Xin Huang, et al.
Journal of Ethnopharmacology|September 16, 2023
Guben Xiezhuo Decoction inhibits M1 polarization through the Raf1/p-Elk1 signaling axis to attenuate renal interstitial fibrosisYue Liu, Jingyi Wu, Shuo Liang, et al.
Phytotherapy Research : PTR|September 17, 2025
Crocin Attenuates Nrf2/GPX4 Mediated Ferroptosis in Obstructive Nephropathy by Selectively Targeting MKK4Ziyun Xu, Liwei Zhu, Jingyi Wu, et al.
Biomolecules|February 25, 2023
Structure-Guided Strategies of Targeted Therapies for Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung CancerZhenfang Du, Jinghan Sun, Yunkai Zhang, et al.
Cell Death Discovery|August 19, 2025
Diverse functions of NLRP3 inflammasome in PANoptosis and diseasesYuanyuan Jiang, Zhiyuan Qiang, Yue Liu, et al.
Pageof 3